David L. Shelton

10.3k total citations · 3 hit papers
62 papers, 7.6k citations indexed

About

David L. Shelton is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, David L. Shelton has authored 62 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cellular and Molecular Neuroscience, 27 papers in Molecular Biology and 14 papers in Physiology. Recurrent topics in David L. Shelton's work include Nerve injury and regeneration (26 papers), Pain Mechanisms and Treatments (14 papers) and Neuropeptides and Animal Physiology (13 papers). David L. Shelton is often cited by papers focused on Nerve injury and regeneration (26 papers), Pain Mechanisms and Treatments (14 papers) and Neuropeptides and Animal Physiology (13 papers). David L. Shelton collaborates with scholars based in United States, United Kingdom and Germany. David L. Shelton's co-authors include Louis F. Reichardt, Stephen B. McMahon, David Bennett, Heidi Phillips, John V. Priestley, Arnon Rosenthal, Martin Koltzenburg, Erin M. Schuman, Hyejin Kang and Carla J. Shatz and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

David L. Shelton

62 papers receiving 7.4k citations

Hit Papers

Mice lacking nerve growth factor display perinatal loss o... 1994 2026 2004 2015 1994 2000 2010 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons
    1994 874 citations Stephen B. McMahon, David L. Shelton et al. profile →
  2. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family
    2000 551 citations Ilona N. Holcomb, Betty Chan et al. The EMBO Journal profile →
  3. Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
    2010 499 citations David L. Shelton et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Shelton United States 36 4.0k 2.3k 2.2k 1.3k 812 62 7.6k
Anders Nykjær Denmark 56 3.4k 0.9× 2.7k 1.1× 5.3k 2.5× 1.3k 1.0× 392 0.5× 134 12.7k
Klaus V. Toyka Germany 66 4.4k 1.1× 2.2k 0.9× 2.9k 1.3× 681 0.5× 376 0.5× 202 12.7k
Eng‐Ang Ling Singapore 55 2.5k 0.6× 1.4k 0.6× 3.3k 1.5× 1.7k 1.2× 433 0.5× 263 11.0k
U. Otten Switzerland 55 5.9k 1.5× 2.1k 0.9× 2.8k 1.3× 2.2k 1.7× 561 0.7× 156 10.3k
Toshihide Yamashita Japan 55 4.8k 1.2× 1.3k 0.6× 4.5k 2.1× 2.6k 1.9× 388 0.5× 329 11.9k
Dirk Troost Netherlands 59 2.5k 0.6× 1.6k 0.7× 4.4k 2.0× 438 0.3× 439 0.5× 197 11.3k
Fletcher A. White United States 43 2.9k 0.7× 2.7k 1.2× 2.1k 1.0× 585 0.4× 474 0.6× 121 6.6k
Asao Hirano United States 51 2.5k 0.6× 1.9k 0.8× 2.5k 1.2× 557 0.4× 523 0.6× 223 10.1k
Frank M. Longo United States 57 6.6k 1.7× 1.9k 0.8× 3.8k 1.8× 2.7k 2.0× 555 0.7× 165 11.2k
Grahame J. Kidd United States 45 2.2k 0.6× 1.0k 0.4× 3.1k 1.4× 1.9k 1.4× 196 0.2× 93 8.9k

Countries citing papers authored by David L. Shelton

Since Specialization
Citations

This map shows the geographic impact of David L. Shelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Shelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Shelton more than expected).

Fields of papers citing papers by David L. Shelton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Shelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Shelton. The network helps show where David L. Shelton may publish in the future.

Co-authorship network of co-authors of David L. Shelton

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Shelton. A scholar is included among the top collaborators of David L. Shelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Shelton. David L. Shelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Oi Kwan, Thomas-Toan Tran, Wei-Hsien Ho, et al.. (2018). RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models. Oncotarget. 9(71). 33446–33458. 20 indexed citations
2.
Walicke, Patricia A., Franz Hefti, Shiao-Ping Lu, et al.. (2018). First-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy pain. PAIN Reports. 3(3). e653–e653. 11 indexed citations
3.
4.
DeVay, Rachel M., Kathy Delaria, Guoyun Zhu, et al.. (2017). Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug Conjugates. Bioconjugate Chemistry. 28(4). 1102–1114. 42 indexed citations
5.
Dorywalska, Magdalena, Russell G. Dushin, Ludivine Moine, et al.. (2016). Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design. Molecular Cancer Therapeutics. 15(5). 958–970. 162 indexed citations
6.
DeVay, Rachel M., et al.. (2015). Common Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Epitopes Mediate Multiple Routes for Internalization and Function. PLoS ONE. 10(4). e0125127–e0125127. 14 indexed citations
7.
Bowman, Christopher, Mark G. Evans, Satoru Oneda, et al.. (2014). Developmental toxicity assessment of tanezumab, an anti-nerve growth factor monoclonal antibody, in cynomolgus monkeys (Macaca fascicularis). Reproductive Toxicology. 53. 105–118. 12 indexed citations
8.
Mantyh, Patrick W., Martin Koltzenburg, Lorne M. Mendell, et al.. (2011). Antagonism of Nerve Growth Factor-TrkA Signaling and the Relief of Pain. Anesthesiology. 115(1). 189–204. 261 indexed citations
9.
Zeller, James R., Kris Poulsen, Janette Sutton, et al.. (2008). CGRP function‐blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat. British Journal of Pharmacology. 155(7). 1093–1103. 73 indexed citations
10.
Hefti, Franz, Arnon Rosenthal, Patricia A. Walicke, et al.. (2005). Novel class of pain drugs based on antagonism of NGF. Trends in Pharmacological Sciences. 27(2). 85–91. 287 indexed citations
11.
Sevcik, Molly A., Joseph R. Ghilardi, Christopher M. Peters, et al.. (2005). Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain. 115(1). 128–141. 239 indexed citations
12.
Kryger, Zol, et al.. (2001). Nerve growth factor inhibition prevents traumatic neuroma formation in the rat. The Journal Of Hand Surgery. 26(4). 635–644. 59 indexed citations
13.
Hongo, Jo-Anne, Gary R. Laramee, Roman Urfer, et al.. (2000). Antibody Binding Regions on Human Nerve Growth Factor Identified by Homolog- and Alanine-Scanning Mutagenesis. Hybridoma. 19(3). 215–227. 28 indexed citations
14.
Holcomb, Ilona N., Betty Chan, Austin Gurney, et al.. (2000). FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. The EMBO Journal. 19(15). 4046–4055. 551 indexed citations breakdown →
15.
Bennett, David, Martin Koltzenburg, John V. Priestley, David L. Shelton, & Stephen B. McMahon. (1998). Endogenous nerve growth factor regulates the sensitivity of nociceptors in the adult rat. European Journal of Neuroscience. 10(4). 1282–1291. 102 indexed citations
16.
Shelton, David L., et al.. (1997). Blockade of Endogenous Ligands of TrkB Inhibits Formation of Ocular Dominance Columns. Neuron. 19(1). 63–76. 262 indexed citations
17.
McMahon, Stephen B., David Bennett, John V. Priestley, & David L. Shelton. (1995). The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nature Medicine. 1(8). 774–780. 358 indexed citations
18.
Pennica, Diane, Kenneth J. Shaw, Todd A. Swanson, et al.. (1995). Cardiotrophin-1. Journal of Biological Chemistry. 270(18). 10915–10922. 382 indexed citations
19.
Koliatsos, Vassilis E., David L. Shelton, William C. Mobley, & Donald L. Price. (1991). A novel group of nerve growth factor receptor-immunoreactive neurons in the ventral horn of the lumbar spinal cord. Brain Research. 541(1). 121–128. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anders Nykjær Breakdown of academic impact, for papers by Klaus V. Toyka Breakdown of academic impact, for papers by Eng‐Ang Ling Breakdown of academic impact, for papers by U. Otten Breakdown of academic impact, for papers by Toshihide Yamashita Breakdown of academic impact, for papers by Dirk Troost Breakdown of academic impact, for papers by Fletcher A. White Breakdown of academic impact, for papers by Asao Hirano Breakdown of academic impact, for papers by Frank M. Longo Breakdown of academic impact, for papers by Grahame J. Kidd
Rankless by CCL
2026